Oral Paricalcitol Reduces the Prevalence of Posttransplant Hyperparathyroidism: Results of an Open Label Randomized Trial

Autor: Amer, H. *, Griffin, M.D., Stegall, M.D., Cosio, F.G., Park, W.D., Kremers, W.K., Heilman, R.L., Mazur, M.J., Hamawi, K., Larson, T.S., Kumar, R.
Zdroj: In American Journal of Transplantation June 2013 13(6):1576-1585
Databáze: ScienceDirect
Externí odkaz: